Joshua Cohen is an independent healthcare analyst. He specializes in healthcare policy, drug pricing, and reimbursement, with a strong focus on consumer health, public health, and digital health. His work has been featured in notable publications such as The New Yorker, Salon Media Group, Inc., and Forbes.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Joshua Cohen's focus is predominantly on the healthcare and pharmaceutical industry, particularly with an emphasis on legal policy regulations and government announcements. His articles often cite data to support his coverage.
When reaching out to Joshua, consider providing insights from experts in the healthcare sector who can offer data-driven analysis or commentary related to drug pricing, public health policies, or regulatory changes within the industry. Additionally, pitches addressing significant government announcements impacting healthcare and pharmaceuticals may align well with his coverage preferences.
While not explicitly stated, it’s clear that Joshua has a keen interest in YouTube channels as per one of his article titles. If you have relevant insights into this aspect of media consumption that intersects with healthcare topics covered by him, it might be worth incorporating such angles into your pitches.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Obamacare faces renewed "death spiral" concerns as premiums are projected to jump 14% in 2027, following last year's 20% increase.
Graham's death sparks questions on cardiac arrest that is caused by an electrical malfunction in the heart that disrupts its pumping action. The heart then stops beating.
It’s possible that the decadeslong trend of rising temperatures globally is leading to the more frequent presence of diseases more typically found in tropical regions.
By: Joshua P. Cohen
Hospitals are sounding the alarm over a growing number of uninsured and underinsured patients, impacting their finances and driving up medical debt. Despite federal mandates for emergency care, declining revenues and rising insurance premiums are systemic consequences. This surge follows the expiration of pandemic-era policies, including Medicaid redeterminations and lapsed ACA subsidies, which have left millions without affordable coverage. Projections indicate further increases in uninsured rates due to tightening eligibility and higher premiums, exacerbating the nation's healthcare affordability crisis. Many Americans face significant medical debt, with universal access remaining a distant goal amid political division.
The U.S. mortality rate reached a record low in 2025. But it lags behind peers due to persistent issues like chronic disease, gun violence and unequal healthcare access.
By: Joshua P. Cohen
The debate between Medicare for All and Medicare by Choice advocates, both of whom seek better affordability, is shaping up to be an interesting one in the coming years.
Though FDA would normally follow a panel’s advice to move ahead with compounded peptides, it’s unclear how it will act, because FDA staff are opposed to easing access.
The INSULIN Act would cap insulin costs for privately insured patients as Congress considers broader measures targeting drug patent practices and competition.
Hospitals often earn large spreads on high-volume branded drugs bought via 340B. Reforms may make hospitals more price-sensitive, raisin uptake of lower-cost biosimilars.
Trump signed an executive order to reshape the childhood vaccine schedule. He made multiple false claims, including repeating the debunked vaccines and autism link.
